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ABSTRACT Multicellular organisms shape development and remove aberrant cells by programmed cell death (’’apoptosis’’).
Because defective cell death (too little or too much) is implicated in various diseases (like cancer and autoimmunity), under-
standing how apoptosis is regulated is an important goal of molecular cell biologists. To this end, we propose a mathematical
model of the intrinsic apoptotic pathway that captures three key dynamical features: a signal threshold to elicit cell death, irre-
versible commitment to the response, and a time delay that is inversely proportional to signal strength. Subdividing the intrinsic
pathway into three modules (initiator, ampliﬁer, executioner), we use computer simulation and bifurcation theory to attribute
signal threshold and time delay to positive feedback in the initiator module and irreversible commitment to positive feedback
in the executioner module. The model accounts for the behavior of mutants deﬁcient in various genes and is used to design
experiments that would test its basic assumptions. Finally, we apply the model to study p53-induced cellular responses to
DNA damage. Cells ﬁrst undergo cell cycle arrest and DNA repair, and then apoptosis if the damage is beyond repair. The model
ascribes this cell-fate transition to a transformation of p53 from ‘‘helper’’ to ‘‘killer’’ forms.INTRODUCTION
Homeostasis of multicellular organisms is maintained by
a delicate balance between cell proliferation and death.
Programmed cell death (apoptosis) is used by organisms to
remove unwanted cells during embryonic development and
immune system maturation, and to remove aberrant cells
that are damaged, infected, or transformed. Failure to trigger
apoptosis can lead to accumulation of damaged DNA and
increased risk of tumor progression (1,2). On the other
hand, over-active apoptosis causes unnecessary cell loss,
resulting in cardiovascular and neurodegenerative diseases.
Thus, understanding the regulation of apoptosis is an impor-
tant goal of basic research in biology and medicine, espe-
cially in the field of molecular oncology (3).
Apoptosis is initiated and executed by a family of prote-
ases called caspases, meaning ‘‘cysteine proteases with
specificity for aspartic acid residue’’. Caspases are present
in normal cells in inactive forms called procaspases. In
response to appropriate signals, procaspases are cleaved to
active forms and proceed to disassemble the cell from inside.
In addition to degrading cellular proteins, caspases activate
DNases that destroy the cell’s genome.
Cells employ two interrelated pathways to trigger pro-
grammed cell death (Fig. 1). (The nomenclature we use for
protein components of apoptotic pathways is explained in
Tables 1 and 2.) The intrinsic pathway responds to intracellular
stresses (hypoxia, DNA damage, etc.) by activating BH3
proteins, a class of proapoptotic proteins possessing only one
BCL2-homology structural domain. Once elevated, BH3
proteins promote the activation of other proapoptotic proteins,
BAX and BAK, by sequestering inhibitors of BAX and BAK,
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a conformational change of BAX. Activated BAX and BAK
form oligomers in the mitochondrial outer membrane,
increasing its permeability to cytochrome c and the second
mitochondria-driven activator of caspase (SMAC). In the cyto-
plasm, cytochrome c binds toAPAF-1 to form an apoptosome,
which activates caspase 9. Caspase 9 then activates the execu-
tioner, caspase 3 (4). SMAC promotes apoptosis by inhibiting
XIAP, an inhibitor of caspase 3 and caspase 9.
The extrinsic pathway responds to extracellular death
ligands (e.g., TNFa) by activating caspases 8 and 10, which
in turn activate executioner caspases 3, 6, and 7 (5,6). In
addition to activating caspase 3 directly, caspase 8 also stim-
ulates the intrinsic pathway by activating BID (4). In this
manuscript, we concentrate on the intrinsic pathway.
Apoptosis has three characteristic physiological features:
1. The cell death response must not be triggered by weak
signals. Procaspases are present in all normal cells. To
survive in a noisy environment, cells must keep these
caspases inactive in the face of minor fluctuations in the
intrinsic and extrinsic pathways. Apoptosis should be
triggered only when the stress level is above some
specific threshold.
2. Once apoptosis is triggered, cells should commit to finish-
ing the process. Caspases destroy the genome and disrupt
cellular structure. To abandon the process half way could
be very dangerous to the organism, generating damaged
cells that might develop into tumors.
3. There is a characteristic time delay between signal and
response: the larger the stress, the shorter the time delay
before apoptosis (7,8).
Programmed cell death is controlled by a complex network
of interacting genes and proteins. Feed forward and feedback
doi: 10.1016/j.bpj.2009.04.053
416 Zhang et al.FIGURE 1 Flow chart of the apoptotic program. Arrows
and bars indicate activation and inhibition, respectively.
See text for details.signals in the network make the dynamic features of the
control system difficult to comprehend intuitively and to
predict reliably by verbal argument alone. To deal with such
complexity, several investigators have constructed quantita-
tive (mathematical) models to investigate the regulation of
programmed cell death in a rigorous and systemic manner
(7,9–19). Building on prior work, we present a model of the
intrinsic pathway that addresses specifically the dynamical
basis of the three characteristic physiological features of
apoptosis. We subdivide the intrinsic pathway into three
modules (initiator, amplifier, and executioner modules) and
show how positive feedback in the initiator module is respon-
sible for the signal threshold and the time delay, and how
the executioner module ensures commitment to cell death.
Numerical simulations of the model are supplemented by
bifurcation analyses that reveal the essential dynamical
features of the network. We also consider how regulation
can go awry under specific circumstances.
Using this model of apoptotic regulation, we seek to under-
stand how cells decide between life and death after DNA
damage. Cells respond to DNA damage by activating a tran-
scription factor, p53. At first, p53 promotes cell survival by
inducing transcription of genes for cell cycle arrest and for
DNA damage repair, thereby giving cells a chance to repair
the damage before it is propagated to a new generation of
cells. If the damage is beyond repair, p53 induces apoptosis
in multiple ways. How p53 chooses between life and death
has been puzzling for a long time (20–22). In this manuscript,
we propose a possible mechanism for the life-or-death deci-
sion. Transient damage promotes p53 in a ‘‘helper’’ form,
Biophysical Journal 97(2) 415–434which induces cell cycle arrest and damage repair. Sustained
DNA damage transforms p53 to a ‘‘killer’’ form that induces
apoptosis. Analysis and simulation of the model show how
p53 helpers and killers might interact with each other in the
cell-fate decision. The model also makes testable predictions
as to how the decision can be perturbed.
Model assumptions and molecular justiﬁcations
Wesubdivide the intrinsic pathway into threemodules (Fig. 2):
the initiator module takes a stress signal as input and outputs
mitochondrial BAX level, the amplifier module describes
how mitochondrial BAX causes the release of cytochrome c
(CytoC) and SMAC, and the executioner module describes
how CytoC and SMAC cooperate to activate caspase 3.
In building the model we must continually make decisions
about what level of detail to keep and what to ignore. We
desire a model that is general enough to apply to real death
decisions made by cells but simple enough to yield to tools
of mathematical analysis (bifurcation theory) and flexible
enough to be tailored (in future) to specific cell types and
experimental circumstances. For example, in the model pre-
sented here, we consider BH3 proteins as a general class of
proapoptotic agents that work by activating BAX proteins,
and we assume (Fig. 2 A) that a stress signal drives the
production of active BH3 proteins. Later, when appropriate,
we can incorporate details of how specific BH3 proteins are
activated by different stresses. For example, NOXA, PUMA,
and BIM levels are upregulated by p53-dependent transcrip-
tional activation in response to DNA damage (23), whereas
BID is activated by caspase-8-dependent cleavage in response
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will approve the spirit in which these modeling decisions have
beenmade, andwill see how to tailor themodel to newsituations
by adding appropriate ‘‘flesh’’ to the ‘‘skeleton’’ we provide.
The initiator module describes BAX activation
by BH3 proteins
When a stress signal is applied to the initiator module, the
BH3 level increases. At first, these BH3 molecules are taken
out of service by binding to inhibitory proteins (BCL2). If the
stress signal is sustained, enough BH3 will accumulate to
saturate the pool of antiapoptotic BCL2 molecules. Free,
active BH3, we assume, induces conformational changes in
BAX that facilitate its insertion into the mitochondrial outer
membrane (24–26). The membrane-localized form of BAX
(BAXm) binds strongly, we assume, to BCL2, releasing addi-
tional free BH3 to promote the conversion of BAX to BAXm.
To prevent cumulative activation of BAX to lethal levels
by multiple, small, accidental activation events, there must
be some protein(s) that inactivate BAX (BAXm / BAX)
at a steady background rate. We assume that this inactivation
process applies to bound forms of BAX (BAXm/BCL2/
TABLE 1 Model components
Notation Explanation
aC9 Active caspase 9, p35/p10
ARF Alternative reading frame of CDKN2A (cyclin-
dependent kinase inhibitor 2A)
ARF/MDM2 Dimer of ARF and MDM2
ASPP Apoptosis-stimulating protein of p53
BAX BCL2-associated X protein
BAXm Active BAX, inserted in mitochondrial outer membrane
BAXm/BCL2 Dimer of BAXm and BCL2
BCL2 Class of antiapoptotic BCL subfamily proteins
BH3 Class of proapoptotic BH3-only subfamily proteins
BH3/BCL2 Dimer of BH3 and BCL2
BH3AC BH3 activators: BIM and t-BID
BH3AC/BCL2 Dimer of BH3AC and BCL2
BH3DR BH3 de-repressors: PUMA, NOXA, BMF, etc.
BH3DR/BCL2 Dimer of BH3DR and BCL2
C3 Active form of caspase 3
C9 Caspase 9, p35/p12
CC, CO Closed and open states of mitochondrial channels
CycE Cyclin E
CytoC Cytochrome c in cytoplasm
CytoCmito Cytochrome c in mitochondria
E2F1 Transcription factor
MDM2 Mouse double minute 2 homolog
p21 Cyclin-dependent kinase inhibitor
p21/CycE Dimer of p21 and cyclin E
p53 Transcription factor, tumor suppressor protein
p73 Member of p53 family
RB Retinoblastoma protein
RB/E2F1 Dimer of RB and E2F1
RBP Phosphorylated RB protein
SMAC Second mitochondria-driven activator of caspase,
in cytoplasm
SMAC/XIAP Dimer of SMAC and XIAP
SMACmito SMAC in mitochondria
XIAP X-linked inhibitor of apoptosis proteinBAX þ BCL2) as well as to free forms. The alternative
assumption that BAX inactivation only applies to the mono-
mer form is invalid (see Appendix B for more details).
From a mathematical point of view, the initiator module
exhibits bistability (alternative stable steady states of low
and high BAX activity) when the inactivating enzyme works
on BAXm/BCL2 as well as free BAXm, but the initiator
module is monostable if the inactivating enzyme works on
free BAXm only.
Bistability in the initiator module is central to our explana-
tion of the signal threshold and time delay that are character-
istic features of programmed cell death. Other authors have
made different assumptions to generate bistable activation
of BAXm (12,13), and further experimental investigations
are needed to clarify the exact molecular mechanism.
In the model, we assume fixed total concentrations of BAX
andBCL2. This assumption allows us to analyze themodel by
phase-plane techniques, as described later. Synthesis and
degradation of BAX and BCL2 are incorporated later in the
p53 model.
The ampliﬁer module describes BAXm-induced release
of CytoC and SMAC
Free BAXm causes an increase in mitochondrial outer
membrane permeability (MOMP) (27). The exact mechanism
of MOMP is not yet clear: BAXm proteins may form oligo-
mers that perforate the membrane, or the outer membrane
may swell and burst (28). In any case, we assume that
BAXm forms tetramers that open channels in the mitochon-
drial outer membrane, as proposed in a previous model (7).
When channels are open (reaction CC/ CO in Fig. 2 B),
many different proapoptotic mitochondrial proteins can
escape into the cytoplasm, including CytoC, SMAC, and
apoptosis-inducing factor (AIF) (29). Among them all,
SMAC and CytoC have been studied most intensively, and
we focus on these two proteins in the current model. SMAC
TABLE 2 Other proteins of interest
Protein name Description
AIF Apoptosis-inducing factor
BID BH3-interacting domain death agonist
BIM Bcl-2 interacting mediator of cell death.
BMF Bcl2-modifying factor
BRN3A, B POU-domain transcription factors
CD95 and Fas Tumor necrosis factor receptor superfamily, member 6
c-FLIP Caspase 8- and FADD-like apoptosis regulator
DR5 Tumor necrosis factor receptor superfamily, member 10b
DYRK2 Dual-specificity tyrosine-phosphorylation-regulated kinase 2
HZF Hematopoietic zinc finger
IGF-BP3 Insulinlike growth-factor-binding protein
JMY Junction-mediating and regulatory protein
NOXA PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1)
P53AIP1 p53-regulated apoptosis-inducing protein 1
P53DINP1 p53-dependent damage-inducible nuclear protein 1
PIG3 p53-induced gene 3
PTEN Phosphatase and tensin homolog
PUMA p53 upregulated modulator of apoptosisBiophysical Journal 97(2) 415–434
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FIGURE 2 Wiring diagrams for a three-module decom-
position of the intrinsic apoptotic pathway. (A) Initiator
module. (B) Amplifier module. (C) Executioner module.
Ovals and rectangles represent proteins in different activity
states. Solid and dashed lines represent chemical reactions
and regulatory signals, respectively. An arrow with two
tails and one head represents the association of two proteins
to form a complex. Black balls on the tails indicate a revers-
ible association and dissociation reaction. An arrow with
one tail and two heads indicates a complex that splits into
two parts, with a chemical transformation (like degradation
or inactivation) of at least one component. Five small
circles represent degradation products. In B, the four
BAXm icons represent a tetrameric complex that opens
channels in the mitochondrial outer membrane. See text
for details.binds to and inhibits XIAP, an inhibitor of caspase 3 and
caspase 9 (30,31), whereas CytoC activates caspase 9.
There are conflicting observations on whether executioner
caspases feed back to BAX activation and CytoC release:
some publications report that genetic knockout of caspases 3
and 7 affects CytoC release (32), whereas others report that
inhibiting caspase activity does not affect BAX activation or
mitochondrial release (33,34). Because of these inconsis-
tencies, we do not incorporate feedback from caspases to the
amplifier module.
The executioner module describes caspase activation
by CytoC and SMAC
CytoC binds to APAF1 and to ATP (or dATP) to form
trimers, APAF/ATP(dATP)/CytoC. Seven such trimers
form an active apoptosome (29). The apoptosome recruits
and activates caspase 9 (35) in the following manner. Cas-
pase 9 is synthesized as inactive procaspase 9 (ProC9 in
Fig. 2 C). Multiple procaspase 9 molecules bind to an apop-
tosome and cleave each other at the Asp315 residue (36). The
cleavage products form a heterodimer, p35/p12 (C9 in
Fig. 2 C). C9 is able to cleave procaspase 3 (ProC3) into
active caspase 3 (C3) (29). Activated caspase 3 in turn
cleaves C9 at Asp330, creating a more active form, p35/p10
(aC9) (37). Caspase 3 may also cleave procaspase 9 to
generate p37/p10 (37), but the physiological significance
of this reaction is unclear, so we ignore it in the model.
Three forms of caspase 9 are considered in the executioner
module: ProC9, C9 (p35/p12), and aC9 (p35/p10). CytoC
causes ProC9 to become C9 and acquire basal protease
activity; caspase 3 further cleavesC9 to generate amore active
form, aC9. Since caspases function as homodimers, we use
factors like [C9]2 to describe caspase activity. Furthermore,
since APAF1 and ATP (dATP) are readily available in the
cytoplasm, we do not address the kinetics of apoptosomeBiophysical Journal 97(2) 415–434formation in the executioner module, although cooperativity
of apoptosome assembly may have dynamical significance,
as discussed elsewhere (10).
Stress-induced release of SMAC from mitochondria facil-
itates apoptosis by inhibiting XIAP, an inhibitor of execu-
tioner caspases. XIAP has a RING domain (30) and acts as
an E3 ubiquitin ligase. It has been demonstrated that binding
of XIAP to C3 (38) or SMAC (39) causes their polyubiquiti-
nation and degradation. XIAP also binds and inhibits C9, and
we assume, in analogy to C3 and SMAC, that this binding
leads to C9 degradation. However, XIAP does not bind to
aC9, because the XIAP-binding site (four N-terminal amino
acids of the p12 subunit) is removed when p12 is cleaved to
p10 by C3 (40). Binding and dissociation of XIAP with
caspase 3, caspase 9, and SMAC are all modeled explicitly,
to take into account the competition of these proteins for
XIAP.
Active caspase 3 (along with other executioner caspases)
cleaves various substrates (4), causing multiple morpholog-
ical changes, including chromatin condensation, nuclear
shrinkage, DNA fragmentation, blebbing of the plasma
membrane, and fragmentation of the cell. The executioner
module uses caspase 3 activity as an indicator of cell death.
As outlined, there is strong positive feedback in the execu-
tioner module: C9 activates C3, which in turn changes C9 to
aC9, a more active form of caspase 9 that is neither inhibited
nor degraded by XIAP.
In response to DNA damage, p53 induces cell cycle arrest
and apoptosis
p53 is a tumor suppressor protein: loss of p53 increases the
chance of tumor development, whereas reactivating p53 has
been proposed as a treatment for cancer (41). p53 suppresses
tumor development by maintaining genome integrity in the
face of DNA-damaging agents. When p53 is compromised,
Dynamics of Programmed Cell Death 419cell lineages accumulatemutations thatmay lead ultimately to
metastatic tumors.
In resting cells, the p53 level is kept low by a negative feed-
back throughMDM2 (Fig. 3A). Any accidental accumulation
of p53 induces production of MDM2, which enhances p53
degradation. DNA damage disturbs the negative feedback
by phosphorylating both p53 and MDM2. Phosphorylated
p53 is more stable, and phosphorylated MDM2 is less active.
DNA damage also enhances degradation ofMDM2. By these
effects, the p53 level is elevated in the presence of DNA
damage (42–45).
p53 induces cell cycle arrest (in eitherG1orG2) through tran-
scriptional activation of p21, 14-3-3s, and GADD45 (46). We
focus on the well-studied pathway by which p53 induces
synthesis of p21,whichbinds to and inhibits cyclinE-dependent
kinase (Fig. 3D). (We use ‘‘CDK’’ to refer to cyclin-dependent
kinases in general and ‘‘CycE’’ to refer to the specific dimer of
cyclin E and its catalytic subunit, Cdk2). p21 and CycE form an
inactive complex. Since we do not know how complex forma-
tion affects the degradation of either p21 or CycE, we assume
that both proteins can be degraded from the p21/CycE complex.
As p21 is degraded, CycE is released and vice versa.
Lack of CDK activity leads to dephosphorylation of the
retinoblastoma (RB) protein. Hypophosphorylated RB binds
to and inhibits E2F1, a transcription factor needed for effec-
tive expression of cyclins E and A (47,48). Thus, if damage
occurs in the G1 phase, CycE and CycA activities will drop
precipitously, and the cell will not progress into the S phase
(DNA synthesis). If DNA damage occurs later in the cycle,
a low level of CycA and a high level of p21 will prevent
accumulation of CycB activity, which is necessary for the
cell to enter mitosis.
p53 triggers apoptosis in multiple ways (22,23), the best
characterized of which is transcriptional activation of BH3proteins (Fig. 3 C), including BID, BIM, PUMA, and NOXA
(46,49). We divide these BH3 proteins into two different
classes, BH3AC and BH3DR. BH3AC (representing BID
and BIM) both binds to BCL2 proteins and activates BAX
directly. BH3DR (representing PUMAandNOXA) only binds
to BCL2 proteins.
p53 induces other proapoptotic proteins, e.g., Fas, DR5,
PIG3, IGF-BP3, p53AIP1, and PTEN. These proteins are
beyond the scope of this model, but they may be included in
future extensions. p53 also induces BAX and APAF1; how-
ever, their induction seems not essential, since active BH3
proteins are able to trigger mitochondrial permeability and
apoptosis even when protein synthesis is blocked with cyclo-
heximide (7).
E2F1 enhances apoptosis
E2F1 participates in p53-induced apoptosis in several ways
(Fig. 3A) (50,51).E2F1-inducedARF inhibitsMDM2, thereby
promoting p53 accumulation (45). E2F1 also induces ASPP1
and 2, JMY, and p53DINP1 (modeled collectively as ASPP
in Fig. 3); these cofactors enhance the efficiency of p53 in
inducing proapoptotic target genes. E2F1 also contributes
to apoptosis independently of p53 by inducing p73, a transcrip-
tion factor in the same family as p53 (52).
Furthermore, E2F1 binds to p53 and retains it in the
nucleus (53). E2F1 also induces APAF-1 and other apoptosis
regulators (51,54,55), but we choose not to include these
regulations in this model.
Differentially modiﬁed p53 can be divided into ‘‘helper’’
and ‘‘killer’’ classes
p53 function is modulated by extensive posttranslational
modifications, including phosphorylation, methylation, acet-
ylation, and ubiquitination (46,56,57). In addition, variousA
D
B
C
FIGURE 3 Wiring diagrams for processes regulating p53
and those regulated by p53. (A) E2F1 enhances apoptosis.
(B) DYRK2 transforms p53 helper to p53 killer. (C) p53
and p73 induce apoptosis. (D) p53 inactivates E2F1. Nota-
tions are as in Fig. 2. See text for details.Biophysical Journal 97(2) 415–434
420 Zhang et al.cofactors (e.g., ASPP1/2, HZF, and BRN3) bind to p53 and
direct it to specific target genes (58). p53 modifications affect
its binding to certain cofactors and vice versa (53,56).
In our model, we assume that posttranslation modification
and cofactor-binding result in two typesof p53: one typeprefers
the induction of apoptosis and the other prefers the induction of
cell cycle arrest (58). We name the proapoptotic type ‘‘p53
killer’’ and the proarrest type ‘‘p53 helper’’ (Fig. 3 B). In the
model, we take Ser46 phosphorylation as an exemplar of the
killer class. When more data on other forms of modification
and cofactor binding are available, the model can be extended
to more subtle distinctions among p53 functional classes.
A dual-specificity tyrosine-phosphorylation-regulated
kinase (DYRK2) is cytoplasmic in resting cells but translo-
cates to the nucleus after DNA damage (58), where it phos-
phorylates p53 on Ser46. When DYRK2 is knocked down
with siRNA, DNA-damage-induced apoptosis is impaired
(59). In the model, p53 accumulates initially in the helper
form, and later it is converted into the killer form by DYRK2.
METHODS
A mathematical model (Appendix A) has been constructed from the
proposed molecular mechanisms in Figs. 2 and 3 by standard principles of
biochemical kinetics, as practiced in Tyson’s research group (60,61). The
mechanisms are based on our review of the experimental literature, as out-
lined in the section ‘‘Model assumptions and molecular justifications’’.
Some assumptions have been made to fill gaps in the available evidence.
The proposed mechanism focuses attention on the molecular components
and reactions that we believe are crucial to understanding apoptotic deci-
sion-making. The time-dependent variables of the model are summarized
in Table 1. Other relevant proteins, not explicitly modeled, are listed in
Table 2.
Time is expressed in minutes, so all rate constants have units min1. All
‘‘concentrations’’ are expressed in ‘‘arbitrary units’’ (i.e., they are dimen-
sionless). Dimensionless concentrations are used because we do not have
enough experimental data to confidently estimate intracellular concentra-
tions of all proteins in the model, and because some variables, such as
[BH3] and [BCL2], represent combinations of several proteins. Values for
the rate constants were chosen by trial and error, to give simulations and
bifurcation diagrams that are consistent with known properties of pro-
grammed cell death. Interested readers can consult previous models for
more information on the rate constants (10,12–14,17–19,62).
We analyze the differential equations with standard tools of dynamical
systems theory (phase-plane analysis and bifurcation theory), and we simu-
late their solutions numerically with standard algorithms for stiff ordinary
differential equations (ODEs). The software tools we prefer are XPP-AUT
(http://www.math.pitt.edu/~bard/xpp/xpp.html) and Oscill8 (http://oscill8.
sourceforge.net/). In the online Supporting Material, we provide ‘‘ode’’ files
for studying our models with these tools. Ode files are easily adapted to other
software environments like MATLAB or Madonna.
RESULTS
The initiator module is responsible for the
threshold and time-delay properties of apoptosis
The initiatormodule (Fig. 2A) can be described by four ODEs
(Appendix A), once we assume constant total concentrations
of BAX and BCL2 proteins ([BAX]T and [BCL2]T). All
numerical simulations and bifurcation calculations are doneBiophysical Journal 97(2) 415–434on these fourODEs.However, togain insight into the dynamics
of the initiator module, it is useful and convenient to write
the four ODEs as a pair of differential equations for the
‘‘slow’’ variables, ½BH3T ¼ ½BH3F þ ½BH3=BCL2 ; and
½BAXmT ¼ ½BAXmF þ ½BAXm=BCL2, where the sub-
script ‘‘F’’ indicates the ‘‘free’’ proteins not bound to BCL2:
d½BAXmT
dt
¼ kf 1 þ kf 2  ½BH3  ½BAX  kb
 ½BAXmT; (1a)
d½BH3T
dt
¼ k0sBH3 þ k00sBH3  Stress kdBH3  ½BH3T;
(1b)
and a pair of algebraic equations for the steady-state concen-
trations of protein complexes,
K1½BH3=BCL2 ¼
½BH3T½BH3=BCL2  ½BCL2T
 ½BH3=BCL2  ½BAXm=BCL2;
(2a)
K2½BAXm=BCL2 ¼
½BAXmT½BAXm=BCL2
 ½BCL2T½BH3=BCL2
 ½BAXm=BCL2; (2b)
where K1¼ kdsBH3BCL2 þ kdBH3
kasBH3BCL2
; K2¼ kdsBAXmBCL2 þ kb
kasBAXmBCL2
. By
formulating the initiator module in this way, we can study
its dynamics using phase-plane methods (Fig. 4 A). The
balance curve (also called a ‘‘nullcline’’) for [BH3]T is a
vertical line according to Eq. 1b. Stress enhances the synthesis
of BH3 and moves the [BH3]T balance curve to the right. The
balance curve for [BAXm]T is S-shaped because of positive
feedback in the initiator module, to be described below.
Wherever the balance curves intersect, the system attains
a steady state. For a small stress signal (Stress ¼ 0.1), the
system has one steady state with a low level of BH3 proteins
([BH3]T ¼ 16) and negligible [BAXm]F (since all BAXm
proteins bind to BCL2 proteins). This steady state (on the
lower branch of the S-curve) corresponds to living cells.
The living state is robust, in the sense that small fluctuations
of BAXm or BH3 levels will decay over time, as the control
system returns to the stable steady state. For a large enough
stress signal (e.g., Stress¼ 0.6), the BH3 balance curve inter-
sects only with the upper branch of the S-curve. Now the
living state is lost, and the system moves to a steady state
of high [BAXm]F (the apoptotic state).
The life-to-death transition occurs when BCL2 is titrated
out by BAXm and BH3, such that [BCL2]Tz [BAXm]T þ
[BH3]T. Given the parameter settings in Appendix A, the
steady state of the initiator module at rest (for Stress ¼ 0.1)
is [BH3]T z [BH3/BCL2] z 16, [BAXm]T z [BAXm/
BCL2] z 33, and [BCL2]F z 31. Hence, [BH3]T must
attain a value of ~47 to titrate out all the remaining BCL2
Dynamics of Programmed Cell Death 421FIGURE 4 Analysis of the dynamics of the initiator
module. (A) Phase plane. Gray dotted line, balance curve
for [BAXm]T; gray vertical lines, balance curves for
[BH3]T (dash dotted, Stress ¼ 0.1; dashed, Stress ¼ 0.6);
black-gray solid line, life-to-death trajectory followed by
[BH3]T and [BAXm]T, plotted as time series in B. Dashes
change color between black and gray every 50 min after the
stress signal is applied. (B) The time series of [BH3]T,
[BAXm]T, [BAXm]F, and [BH3]F. Stress ¼ 0.1 for
t < 30 and 0.6 for t > 30. The black arrow here and later
indicates the time of application of stress. (C) Time lags
between stimulation and BAXm activation for different
values of stress. Open circles, time lags from model simu-
lations; solid line, time lag predicted by Eq. 3. (D) One-
parameter bifurcation diagram. Solid and dashed lines
correspond to stable and unstable steady states, respec-
tively. (E) Phase plane for three different values of
[BCL2]T. Gray dashed line, [BH3]T balance curve for
Stress ¼ 0.6; black dashed, gray dotted, and black solid
lines, [BAXm]T balance curves for [BCL2]T ¼ 60, 80, and
100, respectively. (F) Two-parameter bifurcation diagram.
Black solid lines, saddle-node bifurcation points; gray
dashed line, corresponds to one-parameter bifurcation
shown in D. The region of bistability is between the black
solid lines.molecules. This estimate differs from the calculated threshold
of 43 because the binding of BCL2 to BAXm and BH3 is not
infinitely strong.
To study thedynamics of the transition,wefirst let the system
evolve to the living statewith a small stress signal (0.1) and then
increase the stress signal to 0.6. At the high stress level, the
system starts producing lots of BH3 protein. At first, most
BH3 molecules bind with BCL2, so they cannot activate
BAX. Eventually, BH3 titrates out the BCL2 pool, and excess
BH3molecules are now free to convertBAXtoBAXm.BAXm
displaces additional BH3 from the BH3/BCL2 dimer pool,
thereby speeding up its own production from inactive BAX.
This positive feedback causes the BAXm level to rise quickly,
which will be sufficient to activate the amplifier module
(Fig. 4 B). The trajectory is plotted on the [BAXm]T-[BH3]T
plane (Fig. 4 A). In the final phase of the initiator module, the
system moves along the top branch of the BAXm balance
curve, approaching asymptotically to the steady state.
Note that since [BAXm]T changesmuch faster than [BH3]T,
the trajectory approaches the [BAXm]T balance curve quickly,
and the life-to-death transition is driven by the accumulation of
BH3proteins.As [BH3]T approaches the vertical balance curve
(where d[BH3]T/dt ¼ 0), the rate by which [BH3]T increases
gets smaller. Hence, the location of the vertical nullcline,
at ½BH3T ¼ ðk
0
sBH3 þ k00sBH3  StressÞ=kdBH3, determines the
time needed for the life-to-death transition. For example, forStress ¼ 0.6, the vertical balance curve (at [BH3]T ¼ 46) is
barely above the threshold (~43), so it takes a long time to
make the transition. As stress increases, the vertical balance
curvemoves to the right, and [BH3]T can increasemorequickly
toward the threshold. This effect explains the observed inverse
relationship between signal strength and time lag for initiation
of apoptosis (7). This phenomenon is called ‘‘critical slowing
down’’ in bifurcation theory.
From Eq. 1a, it is easy to derive an analytical approxima-
tion for the lag time, TL,
TL z
1
kdBH3
ln
 
½BH3NT ½BH30T
½BH3NT ½BH3qT
!
; (3)
where ½BH30T ¼
k
0
sBH3 þ 0:1 k00sBH3
kdBH3
is the initial concentra-
tion of BH3 at the resting state (Stress ¼ 0.1),
½BH3NT ¼
k
0
sBH3 þ k00sBH3  Stress
kdBH3
is the final concentration
of BH3, and ½BH3qT ¼ 43 is the threshold concentration of
BH3. In Fig. 4 C, we compare the analytical approximation
(3) with the computed lag time as a function of stress.
Bifurcation theory provides an accurate analysis of how
the activation threshold depends on stress and [BCL2]T.
In the one-parameter bifurcation diagram (Fig. 4 D), we plot
the steady-state level of [BAXm]F as a function of stress. ForBiophysical Journal 97(2) 415–434
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[BAXm]Fz 0. As stress increases, this stable steady state is
lost at a saddle-node bifurcation point (SN1). Beyond the
bifurcation point, the system moves to a stable steady state
with high [BAXm]F. The saddle-node bifurcation point corre-
sponds to the threshold level of stress necessary to fire the initi-
ation module. If stress is reduced after the module has fired,
then the high [BAXm]F state persists until stress drops below
a different, lower threshold (corresponding toSN2 inFig. 4D).
Changing [BCL2]T modulates the threshold stress signal
that activates BAXm. The effect is demonstrated on the phase
plane (Fig. 4 E) and then captured in a two-parameter bifur-
cation diagram (Fig. 4 F). The two lines in this figure trace
the positions of the two saddle-node bifurcations (Fig. 4 D,
SN1 and SN2) with changing levels of total BCL2. The
two-parameter plane is divided into three regions by the
saddle-node lines: the region to the left of SN2 (low stress,
high [BCL2]T, and low [BAXm]F) corresponds to the living
state; the region to the right of SN1 (high stress, low
[BCL2]T, and high [BAXm]F) corresponds to the apoptotic
state; and the region between the SN lines is the bistability
zone. The saddle-node line separating the bistable region
from the apoptotic region determines the threshold stress
level for the initiator module to fire. Clearly the threshold
increases linearly with [BCL2]T, in agreement with the idea
that apoptosis is induced when BCL2 is titrated out.
The ampliﬁer module describes CytoC
and SMAC release
As [BAXm]F increases, oligomers form and open channels
in the mitochondrial outer membrane. CytoC and SMAC
leave mitochondria through these channels and enter the
cytoplasm, where they cooperate to activate the executioner
caspase 3 and then eventually get degraded. Given the
parameter settings in our model, the amplifier module merelyBiophysical Journal 97(2) 415–434relays the signal from BAX in mitochondria to caspases in
the cytoplasm. The all-or-none accumulation of active BAX
in mitochondria membrane results in an all-or-none release
of CytoC and SMAC, which has been observed (7,63).
The executioner module is responsible
for committed cell death
To characterize the executioner module, we use bifurcation
diagrams again. In Fig. 5 A, we plot steady-state caspase 3
activity as a function of [CytoC] for fixed [SMACcyto]T ¼ 2.
It is clear that the executioner module exhibits bistability
and hysteresis, after we have chosen suitable parameter values
for the assumed positive feedback between caspase 9 and
caspase 3.
Since CytoC and SMAC are released together when mito-
chondrial channels open, it is natural to use a two-parameter
bifurcation diagram (Fig. 5 B) to show how caspase 3 activa-
tion depends on simultaneous variations of both proteins.
The cusp-shaped region in this diagram is the region of bist-
ability. The rightmost saddle-node line is the threshold for
caspase 3 activation. A resting cell starts out in the ‘‘living’’
zone with [SMACcyto]Tz 0 and [CytoC]z 0 and low cas-
pase 3 activity (Fig. 5 B, position 1). As CytoC and SMAC
are released from mitochondria in response to stress, the cell
progresses along the black solid line toward the apoptotic
transition (position 2). Once caspase 3 is activated, it stays
active until degradation of CytoC and SMAC drives the
system back toward the ‘‘living’’ zone (caspase 3 inactiva-
tion occurs at position 3).
To compute bifurcation diagrams (with steady-state levels
of active caspase 3), we are compelled to assume constant
levels of total caspase 3 and total caspase 9 and use them as
parameters. This assumption is not correct; rather, the cell
possesses initial supplies of procaspase 3 and procaspase
9, supplies that are used up as the cell executes the deathFIGURE 5 Bifurcation diagrams for the executioner
module. (A)One-parameter bifurcationdiagram (steady-state
C3 activity as a function of CytoC) for [SMACcyto]T ¼ 2.
Notations are as in Fig. 4 D. (B) Two-parameter bifurcation
diagram. Gray lines, loci of saddle-node bifurcations; black
line, trajectory of CytoC and [SMACcyto]T in the cytoplasm
as apoptosis is executed. See text for more details. (C)
Comparison of time courses. Gray lines are computed with
constant total caspase 3 and total caspase 9; black lines are
computed after incorporating synthesis and degradation of
the caspases. See text for more details. (D) Elevated caspase
3 activity is maintained by SMAC-inhibition of XIAP. See
text for details. The time-course simulations in B–D are
computed with the complete apoptosis model: Stress ¼ 0.1
for t < 30 and 1 for t > 30.
Dynamics of Programmed Cell Death 423program. However, time-course simulations (Fig. 5 C), in
which we incorporate the synthesis and degradation of pro-
caspase 3 and procaspase 9, show that the assumption of
constant total procaspases is a good approximation for the first
few hours. Hence, the insights provided by the bifurcation
diagrams are valid for the early stage of apoptosis.
From the time-course simulations in (Fig. 5 C), we see that
procaspase 3 is quickly consumed once apoptosis is triggered,
which means that inflow to the pool of procaspase 3 is very
low.The onlyway tomaintain a high level of caspase 3 in cells
is to shut down the degradation of caspase 3 by XIAP, which
is the function of SMAC (Fig. 5 D). When SMAC is released
into the cytoplasm, it sequesters XIAP. As long as there is
enough SMAC to block XIAP action, caspase 3 stays at
a high level. Later, since SMAC itself is subject to XIAP-
induced degradation, SMAC level drops below the level of
XIAP, and then free XIAP causes degradation of caspase 3.
In a word, excess SMAC protein is important for sustained
caspase 3 activity and committed cell death through the
intrinsic apoptosis pathway.
The model captures the dynamic features
of normal apoptosis
After analyzing eachmodule separately, we put them together
to simulate the progression of apoptosis inwild-type cells.We
start the simulation from the resting state (Stress ¼ 0.1) and
elevate the stress signal to different levels at t ¼ 30. Model
simulations (Fig. 6 A) exhibit the three characteristic features
of apoptosis (7,18,64):
1. BAXm and caspase 3 are activated only when stress
exceeds a certain threshold (~0.5 for the parameter values
used here). The threshold property protects cells from
unexpected fluctuations in stress.
2. In response to suprathreshold stress signals, there is
a distinct time lag before caspase 3 is activated. As stressincreases, the time lag decreases. However, neither the
amplitude nor the duration of caspase 3 activity is sensi-
tive to the level of stress above the threshold. The time
delay gives cells some time before making the final
commitment to apoptosis. If the stress signal disappears
soon, cells may survive.
3. Once caspase 3 is activated, its activity stays high for
a certain period of time, ensuring that the apoptotic process
is carried to completion. This commitment feature is essen-
tial to prevent cells that have been damaged by apoptotic
DNases from reverting to a proliferative state and propa-
gating their damaged DNA to progeny cells.
The sequential activation of BAXm and caspase 3 agrees
with experimental observations. When increasing levels of
death ligand (like TRAIL) are used to induced apoptosis,
decreasing time lags are observed before MOMP, but cas-
pase 3 activation after MOMP is always quick (7,18).
Cells have good reason to control apoptosis upstream of
BAX activation. Mitochondria generate most of the cell’s
energy supply, so it makes sense not to permeabilize the
mitochondrial outer membrane before the cell determines
to self-destruct. Release of other mitochondrial proteins
may cause considerable caspase-independent damage (65).
Now we take a closer look at the events between MOMP
and caspase 3 activation (Fig. 6 B). SMAC is released into
the cytoplasm, where it binds to XIAP and reduces the pool
of free inhibitors. At the same time, caspase 9 is activated by
cytoplasmic CytoC. Caspase 9 is free to activate caspase 3,
since there is no XIAP to inhibit caspases 3 and 9. Caspase
3 then converts caspase 9 into a more active form, bringing
about an explosive increase in caspase 3 activity. Caspase 3
activity stays high until SMAC level is greatly reduced and
no longer able to hold XIAP inactive. Prolonged caspase 3
activity, which has been observed experimentally (64,66),
ensures complete cleavage of its cellular substrates.FIGURE 6 Simulated protein time courses demon-
strating how the model captures the dynamical features
of a normal apoptotic response. (A) Caspase 3 activity
and free BAXm level. For 0 < t < 30, Stress ¼ 0.1, and
for t > 30, stress is raised to different levels. (B) Time
courses of other proteins for the case Stress ¼ 1 for t > 30.Biophysical Journal 97(2) 415–434
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degraded enough to release XIAP. Since the cell is already
‘‘dead’’ by this time, caspase inactivation in the model is
a moot point. However, if SMAC protein level is low or
XIAP protein level is high, the executioner module may
allow for premature inactivation of caspase 3. Cells compro-
mised in this fashion have the potential to develop into
tumors. The loss of commitment in mutant cells will be
addressed in more detail later.
The model mimics the dynamics of apoptosis
in mutants and provides mechanistic insights
We test the model by examining its ability to simulate mutant
phenotypes. To simulate a mutant cell line, we change the
values of appropriate parameters in the model. To mimic
XIAP overexpression or deficiency mutants, we change
[XIAP]T from its wild-type value of 6 to 13 or 1, respectively.
To mimic cells with double deficiency of BID and BIM, we
change kf2 to zero. We start each mutant simulation from
the resting state, Stress¼ 0.1, and then set Stress¼ 1 at t¼ 30.
Caspase 3 activity and free BAXm level in wild-type and
double-deficient cells are plotted in Fig. 7 A. In wild-type
cells, caspase 3 is activated after a lag of ~70 min and stays
active for another 250 min. In cells deficient for BID and
BIM (kf2¼ 0), there is a slightly longer time delay, but caspase
3 activity is eventually high enough and sufficiently sustained
to commit the cell to death, as observed experimentally (67).
The time course of free BAXm level reveals a defect in
BAX activation when BID and BIM are knocked out;
however, this malfunction of the initiator module is not
seen as a significant defect in the apoptotic response, because
the amplifier module and executioner module can still turn
a graded response of BAXm into a committed response of
caspase 3 activity. To observe the consequences of the muta-
tion would require closer examination of BAX dynamics inBiophysical Journal 97(2) 415–434the mitochondria. We propose below an experiment to
achieve this.
Caspase 3 activities in wild-type and mutant cells with two
different levels of XIAP are plotted in Fig. 7 B. In XIAP-defi-
cient mutants ([XIAP]T ¼ 1), caspase 3 is activated as in
wild-type cells, but caspase 3 activity stays high for a longer
time. Hence, XIAP-deficient cells are surprisingly normal
(68); they respond properly to small and large stress signals.
The normal behavior of XIAP-deficient cells is due to a func-
tional compensation of the defect by the initiator module.
On the other hand, when XIAP is over-expressed
([XIAP]T¼ 13), caspase 3 is activated only transiently, which
is consistent with the observation of partial caspase 3 activa-
tion in XIAP overexpressing cells (18). In this case (Fig. 7C),
as SMAC is first released frommitochondria, it inhibits XIAP
and allows caspase 3 activation. However, SMAC soon loses
its control over XIAP, since the XIAP level is high. Free
XIAP binds to caspase 3 and causes its degradation. Thus,
caspase 3 stays active for only a short period of time.
The p53 module governs dynamical cell fates
after DNA damage
In this section, we use bifurcation diagrams to study the p53
signaling module (Fig. 3). First, we take p53 ‘‘helper’’ and
‘‘killer’’ activities to be fixed parameters and examine the
response of the system in terms of E2F1 activity and BAX
activation. (Since, as we have shown, BAX activation by
the initiator module is sufficient to trigger apoptosis in wild-
type cells, we need not trace the process beyond BAXm). In
Fig. 8 A, we set p53 killer to the low level of 1 and plot
steady-state E2F1 activity as a function of the p53-helper
level. At low p53-helper level, E2F1 activity stays high, cor-
responding to proliferating cells. As the p53-helper level
increases, E2F1 becomes inactived by RB (see Fig. 3 D),
resulting in cell cycle arrest. The high E2F1 state is lost byFIGURE 7 Comparisons of time courses for wild-type
and mutant cells. (A) Time course of C3 activity, as well
as free [BAXm] level for wild-type cells and the double
knock-out mutant (bid/ bim/; kf2 ¼ 0). Stress is raised
from 0.1 to 1 at t ¼ 30. (B) Time course of C3 activity for
wild-type and two different levels of [XIAP]T. (C) Loss of
commitment for cells overexpressing XIAP. See text for
more details.
Dynamics of Programmed Cell Death 425FIGURE 8 The transformation from p53 helper to p53
killer in response to prolonged DNA damage. (A) E2F1
inactivation by p53 helper: one-parameter bifurcation
diagrams for two different levels of p53 killer. (B)
BAXm activation by p53 killer: one-parameter bifurcation
diagrams for three different levels of p53 helper. For A and
B, there are three steady states between the saddle-node
(SN) bifurcations; the middle state is unstable. (C) Two-
parameter bifurcation diagram for p53 killer and p53
helper. Solid and dashed lines trace saddle-node bifurca-
tions in A and B, respectively. (D) Dynamical cell fate in
response to DNA damage. DNA damage ¼ 0 for 0 <
t < 1000, and DNA damage ¼ 10 for t > 1000.a saddle-node bifurcation, due to the positive feedback
between CycE and E2F1 (CycE/Cdk x RB x E2F1 /
CycE). When p53 killer is increased (to 4), a little less p53
helper is needed to inactivate E2F1, but the effect is inconse-
quential (SN1 shifts only slightly), because the ability of p53
killer to induce p21 is assumed to be very small.
Next, we set p53 helper to 0 and investigate the p53-killer
effect (Fig. 8 B). At a low level of p53 killer, [BAXm]F stays
low.Asp53-killer level increases,BH3proteins are introduced.
At first, there is enoughBCL2 to sequester all BAXm andBH3
molecules, and [BAXm]F remains low. As the p53-killer level
passes a certain threshold, BCL2 proteins are titrated out and
thepositive feedbackbetweenBAXmandBH3bringsa sudden
increase of active BAXmmolecules (at SN3), causing MOMP
and caspase 3 activation, as described earlier.
Increasing the p53-helper level shows dual effects on
p53-killer-induced apoptosis (Fig. 8 B). When p53 helper is
increased a little (p53 helper ¼ 2), apoptosis is inhibited: a
little more p53 killer is required to activate BAXm. However,
further increase, to p53 helper ¼ 4, promotes apoptosis with
considerably less p53 killer needed to activate BAXm (the
position of SN3 drops significantly).
A two-parameter bifurcation diagram (Fig. 8 C) lays out
the interactions between p53 helper and p53 killer. In this
diagram, solid lines trace the pair of saddle-node bifurcation
points (black, SN1; gray, SN2) by which p53 helper induces
cell cycle arrest, and dashed lines trace the pair of saddle-
node bifurcation points by which p53 killer induces
apoptosis (black, SN3; gray, SN4). The solid lines are nearly
horizontal, in agreement with the fact that p53 killer hardly
affects p53-helper-induced cell cycle arrest.
The dashed lines have two features. First, they move
leftward with increasing p53 helper. Because p53 helper
contributes to the production of BH3 proteins, increasingthe p53-helper level promotes the induction of apoptosis by
p53 killer. Second, the dashed lines are N-shaped, which
reflects the saddle-node bifurcations observed in Fig. 8 A.
For a low level of p53 helper (below the line for SN2),
E2F1 is active and enhances p53-induced apoptosis (see
Fig. 3 for the molecular mechanism); hence, the p53 killer
level needed to induce apoptosis is low.Whenp53helper level
is increased above the line for SN1, E2F1 is inhibited and
unable to promote apoptosis; thus, the threshold level of p53
killer is elevated abruptly. Positive feedback in E2F1 regula-
tion (described above) is necessary for bistability observed
in Fig. 8 A and the N-shaped bifurcation curves in Fig. 8 C.
Between the lines for SN1 and SN2, the bifurcation anal-
ysis becomes more complicated and beyond the scope of this
manuscript.
Now that we know the different functions of p53 helper and
p53 killer, we can investigate how these two forms are regu-
lated in response to DNA damage (Fig. 8 D), using the
ODEs for the p53 module in Appendix A. In the absence of
DNA damage, the equations reach a steady state, correspond-
ing to resting cells. As a damage signal is applied, [MDM2]
decreases and [p53] increases. At first, p53 accumulates in
the helper form; cell cycle progression is arrested and
apoptosis is inhibited. If the damage is repaired quickly, the
cell may go back to proliferation. Sustained DNA damage,
on the other hand, causes DYRK2 translocation to the
nucleus, where it transforms p53 helper to p53 killer. p53
killer induces BH3 proteins more efficiently than p53 helper.
Furthermore, E2F1 is reactivated as the p53 helper level
decreases, and active E2F1 helps p53 to induce apoptosis.
Experimental observations support the dynamical changes
proposed by the model. For example, when p53 is activated
by DNA damage, the cell cycle arrest protein p21 is induced
earlier than the apoptotic protein PUMA (69).Biophysical Journal 97(2) 415–434
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Programmed cell death (apoptosis) has three defining dynam-
ical features: a signal threshold that must be exceeded to elicit
cell death, a long and variable time delay between the signal
and the response, and irreversible commitment to cellular
disassembly once the terminal proteases have been activated.
From the available experimental data we have identified those
molecular interactions that, we believe, are key components
of the mechanisms ensuring these properties of programmed
cell death. Using a mathematical model, we show how the
dynamical features arise from the identified interactions.
The model attributes the signal threshold and time delay to
positive feedback between proapoptotic BH3 and BAX
proteins mediated by antiapoptotic BCL2 proteins. Activated
BAX proteins release cytochrome c and SMAC from mito-
chondria, and these signaling proteins stimulate a positive
feedback between caspase 9 and caspase 3 that ensures irre-
versible commitment to cell dissolution. As an example of
how this cell-death response network responds to stress
signals, we propose a model of how p53 responds to DNA
damage by eliciting, at first, cell cycle arrest and damage
repair, and later, if the damage persists, cell death. The
sequence of protein expressions and posttranslational modifi-
cations, generated by the model, are in qualitative agreement
with experimental observations.
Several other studies using computational modeling to
understand the molecular machinery underlying apoptosis
have been published in recent years. Each model has its
own unique scope and emphasis. Our model has been
designed to combine what we believe are the best character-
istics of previous modeling efforts with some novel ideas and
specific goals of our own.
We are interested in how cells respond to severe DNA
damage by cell cycle arrest and, ultimately, programmed cell
death. Hence, we choose to emphasize the role of BH3 proteins
in sensing the damage signal. By contrast, Albeck et al. (7,19)
are interested in how apoptosis is stimulated by external
signaling factors, so their model starts from the binding of
a death ligand to its membrane receptor. Their model is con-
cerned with, among other things, interactions between the
extrinsic and intrinsic pathways of apoptosis. The model by
Rehm et al. (18) starts from mitochondrial release of CytoC
andSMAC, to focuson the roleofXIAP in caspase3 activation.
We are particularly interested in themolecular mechanisms
that underlie the threshold, time-lag, and commitment proper-
ties of apoptosis, which leads us to select some molecular
interactions for our model and disregard others. The biochem-
ical details we have disregarded may prove important in
addressing other issues. For example, we do not model apop-
tosome assembly explicitly, but this process plays an impor-
tant role in the model of Bagci et al. (10), who attribute
bistability in caspase 3 activation to cooperativity in apopto-
some formation (Apaf1 þ CytoC þ caspase 9 þ ATP /
Apoptosome) and feedback from caspase activation to CytoCBiophysical Journal 97(2) 415–434release from mitochondria. In addition, we disregard the feed-
back from caspase 3 to caspase 8 through caspase 6, but this
positive feedback loop plays a significant role in the model of
Eissing et al. (14), generating bistability in caspase 3 activation.
The final stage of programmed cell death is a transient
disassembly of the cell (a dying cell is certainly not at
a steady state). However, preliminary stages of the process
have time to reach a pseudosteady state before final activa-
tion of executioner caspases. Furthermore, an analysis of
steady states of the several stages of programmed cell death
is very informative about the transient behavior of the control
system, as we have shown. Hence, we use bifurcation
diagrams extensively to reveal how qualitative features of
the apoptotic response are related to network motifs in the
reaction mechanism and to quantitative aspects of the
network, such as gene expression levels and kinetic rate
constant changes induced by mutations. By contrast, Albeck
et al. (7,19) are interested in comparing their model with
experimental observations, so they rely heavily on numerical
simulations. To capture the stochastic effects in the apoptotic
response, Chen et al. (12) use agent-based simulations to
study their model’s predictions. Stochastic effects in
apoptosis have also been addressed by Eissing et al. (14,62).
Our emphasis on positive feedback, bistability, thresholds,
and time lags is based in part on previous studies of pro-
grammed cell death. Legewie et al. (17) have studied two
possible positive feedback loops between caspase 3 and cas-
pase 9, and we adopt their conclusion that these caspases do
indeed help each other downstream of apoptosome formation.
In a similar way, ourmodel of the initiator module bearsmany
similarities to the work of Chen et al. and Cui et al. (12,13),
and we refer to those articles for more details. Our model
also inherits many ideas about time lags and commitment
from the work of Albeck et al. (7,19), but we place more
emphasis than they do on positive feedback and bistability
in the initiatormodule and the executionermodule.We accept
their point that programmed cell death is a transient process
that need not have (and, indeed, cannot have) a stable steady
state of high executioner-caspase activity. Nonetheless, we
agree completely with authors of earlier modeling studies
that the apoptotic control system must have a stable ‘‘OFF’’
state (the living state) and a distinct threshold stress level
for initiating the cell death program. Like the group in Nan-
jing, China (12,13), we associate the thresholdwith bistability
in the initiator module. We also propose that bistability in the
executioner module supports the cell’s commitment to
apoptosis once caspase 3 is activated. Because our model
has bistability in two different stages of the process, neither
one of the bistable modules is necessary for a well-orches-
trated apoptotic response. But, if both positive feedback loops
are compromised, then the cells will no longer be able tomake
a clear life or death decision, as observed in cells inwhich both
BCL2 and XIAP are disrupted (7).
One of the most remarkable discoveries from recent obser-
vations of programmed cell death in single cells is the great
Dynamics of Programmed Cell Death 427cell-to-cell variability in the latency period between the
initial stress signal and the abrupt onset of MOMP (19).
Our model attributes this extreme variability to the phenom-
enon of ‘‘critical slowing down’’ close to a saddle-node
bifurcation in the initiator module. The model predicts that,
if the positive feedback between BH3 and BAXm is missing
(e.g., in a double knock-out of BIM and BID), the activation
of BAX is no longer governed by a saddle-node bifurcation
(Fig. 9 A) and the latency period from cell to cell should now
be less variable.
In the initiator module, we propose that BAX activation
corresponds to an irreversible transition between stable
steady states of low and high BAX activity. This transition
serves as a clear signal for downstream events, in particular,
the transition of the outer mitochondrial membrane from an
impermeable to a highly permeable state (MOMP). Bistabil-
ity of the BH3-BAX initiator module can be tested by the
following experiments.
It may be hard to control a stress signal precisely, but it
should be possible to control the level of nondegradable
BH3 protein in a cell and thereby to observe bistability in
the activation of BAX. In Fig. 9 A, we fix total BH3 to
different levels and compute the activity of BAX. When
[BH3]T is just above 40, BAX shows bistable activation. To
carry out the experiments in vivo, BAX protein could bemonitored by a green fluorescent protein tag: inactive BAX
molecules are dispersed in the cytoplasm, but active BAX
molecules should translocate to the mitochondrial membrane.
BH3 proteins could then be injected to activate BAX, and
BH3 antibodies could be introduced subsequently to bring
the BH3 level down. To prevent cell destruction by active
executioner caspases, the experiments should be carried out
in cells unable to activate executioner caspases, like cells defi-
cient for both SMAC and CytoC or cells with all caspases
inhibited.
A protocol for the experiment in this case could be as
follows. Starting from a low BH3 level (Fig. 9 A, position a),
injection of a sufficiently large amount of BH3 will bring the
BH3 level to, say, position c, and therefore activate BAX.
Later, the right amount of BH3 antibody can be used to bring
the BH3 level down to position b. If our picture holds, BAX
should stay on the upper branch of the diagram in Fig. 9 A
and remain activated.
This experiment should be repeated using a slightly
different protocol: before injecting BH3 into the cell, it
should be preincubated with BH3 antibody. After injecting
the mixture into the cell, the BH3 level will go from posi-
tion a to position b in Fig. 9 A, and BAX protein should
stay on the lower branch and remain inactive. From these
two experiments, one can conclude that, for the BH3 levelFIGURE 9 Calculations in support of experimental tests
of the model. (A) One-parameter bifurcation diagram for
the initiator module, corresponding to wild-type cells
(black line) and double-knock-out (bid D bim D) mutant
(gray line, kf2 ¼ 0). Solid and dashed lines correspond
to stable and unstable steady states, respectively. Note
that bistability is lost in the double-knock-out mutant.
Points a–c indicate the values of [BH3]T for the proposed
experimental test. Black, white, and gray rectangles indi-
cate active, inactive, and bistable BAXm, respectively.
See text for more details. (B) Two-parameter bifurcation
diagram. Gray solid lines, saddle-node bifurcation points;
black solid and black dashed lines, two proposed ways to
elevate protein levels. See text for more details. (C) Simu-
lated time courses of caspase 3 activity (black dashed line)
and the level of total BH3 proteins (black solid line). A
periodic stress signal (gray dashed line) is begun at
t ¼ 60, with Stress ¼ 1.25 for 120 min and Stress ¼ 0.1
for 120 min. The synthesis and degradation rates of BH3
are decreased by 10-fold, ks
0
BH3 ¼ 0.01, ks00BH3 ¼ 0.06
and kdBH3¼ 0.001. (D) Two-parameter bifurcation diagrams
of the model corresponding to wild-type cells ([XITP]T¼ 6,
gray) and XIAP deficient cells ([XIAP]T ¼ 1, black).
(E) Simulated time courses of caspase 3 (solid lines) and
Procaspase 3 (dashed lines) corresponding towild-type cells
([XITP]T¼ 6, gray) andXIAP deficient cells ([XIAP]T¼ 1,
black). The initial concentrations of CytoC and SMAC
inside the mitochondria are set at 200. Stress ¼ 0.1 for
0 < t < 30 and Stress ¼ 1 for t > 30. (F) Simulated time
courses of [p53helper] (dashed lines) and [p53killer] (solid
lines) for wild-type cells (gray) and DYRK2 mutant cells
(black). The DYRK2 mutant (enhanced nuclear uptake) is
mimicked by setting kin at 0.0015. DNA damage ¼ 0 for
0 < t < 1000; DNA damage ¼ 10 for t > 1000.Biophysical Journal 97(2) 415–434
428 Zhang et al.of position b, BAX activation is bistable. We cannot state
precisely the amounts of BH3 protein and BH3 antibody
needed to move the system between points a, b, and c in
Fug. 9 A, because the current model predicts bistability
only as a qualitative feature of the control system. The
model is not yet sufficiently calibrated by quantitative
data to judge the precise protein levels that define the region
of bistability.
If these experiments successfully locate a region of bistabil-
ity, the information can be used to guide other experiments
aiming to test the location of the bistability region in the
two-parameter bifurcation diagram (Fig. 9 B)—experiments
in which both BH3 and BCL2 proteins are to be injected
into cells. Our model predicts that BAX activity depends on
the sequence in which BH3 and BCL2 are injected. In partic-
ular, BAX gets activated if BH3 proteins are injected before
BCL2 proteins, which corresponds to the path a/ c/ e
in Fig. 9 B. On the contrary, BAX remains inactive if BCL2
proteins are injected before BH3 proteins, which corresponds
to the path a/ d/ e.
Next we propose a series of experiments in which BH3
proteins are induced by pulsatile signals. Pulses of p53 acti-
vation (over a period of 5–7 h) after DNA damage have been
observed in various settings (70,71). Nonetheless, we are not
aware of any experimental work directly addressing the
effects of p53 pulses on BH3 protein level. We suggest
here two possibilities. First, each p53 pulse induces produc-
tion of a certain amount of BH3 protein, which may accumu-
late enough to trigger programmed cell death. The BH3 level
in this way ‘‘counts’’ the number of pulses. Because it is the
collective contribution of p53 pulses that triggers pro-
grammed cell death, we call this possibility the ‘‘pulse coop-
eration route’’ to apoptosis. Alternatively, the initial pulses
of p53 appear predominantly in a p53 helper form, which
is inefficient in inducing BH3, and thus the pulses contribute
little to BH3 accumulation. As DYRK2 kinase increases in
the nucleus, the later pulses of p53 proteins transform into
the killer form, which presumably induces enough BH3 to
trigger programmed cell death. We call this possibility the
‘‘pulse modification route’’ to apoptosis.
The two routes are not mutually exclusive. The relative
contribution of each route depends on the BH3 turnover rate.
If BH3 turns over rapidly, its level decreases quickly between
p53 pulses, and it is hard for the system to ‘‘count’’ the pulses.
This is the case in themodel presented here,which relies on the
pulse modification route to apoptosis. On the other hand, if
BH3 turns over slowly, the pulse cooperation route will play
a more significant role. In Fig. 9 C, we decrease the rates of
BH3 synthesis and degradation by 10-fold, and, as a result,
it takes six pulses of p53 to produce enough BH3 to activate
caspase 3. (The stress signal in Fig. 9C promotes BH3produc-
tion and thus mimics the putative effect of p53 pulses).
The BH3 turnover rate depends on cellular context. For
example, the half-life of BIM varies from 3 h to >8 h,
depending on whether or not BIM is phosphorylated (72).Biophysical Journal 97(2) 415–434We suggest that measurement of BH3 turnover in response
to p53 pulses in cells undergoing programmed cell death
will help to distinguish between the ‘‘pulse cooperation’’
and ‘‘pulse modification’’ routes to apoptosis.
Third, we attribute cell-death commitment to high caspase
3 activity, sustained by slow degradation of SMAC and
CytoC. Hence, in our model, the duration of caspase 3
activity is proportional to the initial level of SMAC within
mitochondria (simulations not shown). Experiments show
that the initial level of SMAC in cells can be increased with
external vectors carrying additional copies of the SMAC
gene or decreased with siRNA, and caspase 3 activation
dynamics can be measured in both cases. For example, Al-
beck et al. decreased SMAC level with siRNA and observed
partial cleavage of caspase3 substrates (7), but the duration of
caspase 3 activity remains to be measured in future studies.
Fourth, the model reveals three functional regions of the
executioner module (Figs. 5 B and 9 D). In the absence of
stress, cells persist in the living state (Fig. 9 D, point A)
with low caspase 3 activity but plenty of procaspase 3.
When stress is applied, cells enter the apoptosis region
(point C) to activate caspase 3. In cells deficient for XIAP,
the apoptosis region is expanded (Fig. 9 D) and less SMAC
and CytoC are needed to induce apoptosis. By reducing mito-
chondrial levels of SMAC and CytoC with siRNAs, one can
limit the stimulus of the executioner module to, say, point B
in Fig. 9 D. For cells with a normal XIAP level, point B is
in the living region, and caspase 3 remains inactive. In cells
deficient for XIAP, point B is in the apoptosis region, and
caspase 3 is activated. The different caspase 3 dynamics in
the two cases are shown in Fig. 9 E.
Fifth, in the p53 model, nuclear translocation of DYRK2
serves as a ‘‘timer’’ that controls cell fate. Shortly after DNA
damage, DYRK2 is mostly cytoplasmic; p53 accumulates in
its helper form and induces cell cycle arrest. If DNA damage
is sustained, more and more DYRK2 translocates to the
nucleus, where p53 transforms to the killer form and induces
apoptosis. DYRK2 localization can be manipulated with
nuclear export signals and nuclear localization signals.
Favoring nuclear localization will accelerate apoptosis (Fig. 9
F), whereas favoring nuclear export will delay apoptosis.
Our model of the intrinsic pathway of programmed cell
death is intended as a ‘‘plug-and-play’’ subunit of more
complex computational models, yet to be developed, of the
signaling network of mammalian cells (3). To show how
to use the model in this way, we have plugged it into a simple
model of the p53 signal processing unit, which receives input
from the DNA-damage surveillance mechanism and relays
the signal to the cell-cycle control machinery as well as to
the programmed cell-death pathway. In the near future, we
and other modeling groups will use mathematical models
in this way to build more sophisticated, accurate, and predic-
tive simulators of how mammalian cells respond to myriad
input signals by appropriate changes in gene expression,
movement, cell growth and division, and cell death.
429APPENDIX A: EQUATIONS, PARAMETERS
AND INITIAL CONDITIONS
Initiator module (four ODEs, 13 parameters,
and wiring diagram in Fig. 2 A)
d½BAX
dt
¼ k f1 þ k f 2  ½BH3  ½BAX
þ kb  ½BAXmFþ k b  ½BAXm=BCL2
d½BAXm=BCL2
dt
¼ k asBAXmBCL2  ½BAXmF ½BCL2F
k dsBAXmBCL2  ½BAXm=BCL2
kb  ½BAXm=BCL2
d½BH3F
dt
¼ k0sBH3 þ k00sBH3  Stress k dBH3  ½BH3F
kasBH3BCL2½BH3F½BCL2F
þ kdsBH3BCL2½BH3=BCL2
d½BH3=BCL2
dt
¼ k asBH3BCL2  ½BH3F ½BCL2F
k dsBH3BCL2  ½BH3=BCL2
k dBH3  ½BH3=BCL2
½BAXmF¼ ½BAXT½BAX  ½BAXm=BCL2
½BCL2F¼ ½BCL2T½BH3=BCL2  ½BAXm=BCL2
½BCL2T¼ 80; ½BAXT¼ 100; Stress ¼ 0:1; k f 1 ¼ 1;
k f 2 ¼ 3; kb ¼ 2
k asBAXmBCL2 ¼ 90; k dsBAXmBCL2 ¼ 0:05; k asBH3BCL2 ¼ 10;
k dsBH3BCL2 ¼ 0:01
k
0
sBH3 ¼ 0:1; k00sBH3 ¼ 0:6; k dBH3 ¼ 0:01
init ½BAX ¼ 66:6; ½BAXm=BCL2 ¼ 33:4; ½BH3F¼ 0;
½BH3=BCL2 ¼ 16
Ampliﬁer module (ﬁve ODEs, seven parameters,
and wiring diagram in Fig. 2 B)
d½CO
dt
¼ kopen  ½BAXmmF
½CT½CO k close  ½CO
d½SMACmito
dt
¼ ½CO  ½SMACmito
d½CytoCmito
dt
¼ ½CO  ½CytoC mito
d

SMACcyto

T
dt
¼ 3  ½CO  ½SMACmito  kdSMACcyto
 ½SMACFk dsx  ½SMAC=XIAP
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Executioner module (eight ODEs, 24 parameters,
and wiring diagram in Fig. 2 C )
d½CytoC
dt
¼ 3  ½CO  ½CytoCmito  kdCYTOC  ½CytoC
kopen ¼ 10; m ¼ 4; kclose ¼ 10000; kdSMACcyto ¼ 0:0001;
kdCYTOC ¼ 0:005 3 ¼ Vmito
Vcyto
¼ 0:01; ½CT¼ 1
init ½SMACmito ¼ 1600; ½CytoC mito ¼ 800;
½CytoC ¼ 0:1; SMACcytoT¼ 0; ½CO ¼ 0;where
d
½ProC9
dt
¼ ksproc9  kdproc9  ½ProC9  ksc9
 ½ProC9  ½CytoCn
d
½ProC3
dt
¼ ksproc3  kdproc3  ½ProC3 

k
0
ac3 þ k
00
ac3
 ½C9nþ k000ac3  ½aC9n

 ½ProC3
d½C9
dt
¼ ksC9  ½CYTOCn ½ProC9  kdc9  ½C9
k0aC9 þ k00aC9  ½C3n  ½C9
kas9x  ½C9  ½XIAPFþ kds9x  ½XIAP=C9
d½aC9
dt
¼ k0aC9 þ k00aC9  ½C3n  ½C9  kdac9  ½aC9
d½C3
dt
¼ k0aC3 þ k00aC3  ½C9nþ k000aC3  ½aC9n
ð½proC3Þ  kdC3  ½C3
kas3x  ½C3  ½XIAPFþ kds3x  ½XIAP=C3
d½XIAP=C9
dt
¼ kas9x  ½C9  ½XIAPFkds9x
 ½XIAP=C9  kd9x  ½XIAP=C9
d½XIAP=C3
dt
¼ kas3x  ½C3  ½XIAPFkds3x
 ½XIAP=C3  kd3x  ½XIAP=C3
d½SMAC=XIAP
dt
¼ kassx  ½SMACF ½XIAPFkdssx
 ½SMAC=XIAP  kdsx  ½SMAC=XIAP
½SMACF¼

SMACcyto

T
½SMAC=XIAP
½XIAPF¼ ½XIAPT½SMAC=XIAP  ½XIAP=C3
½XIAP=C9
ksproc3 ¼ 0:002; kdproc3 ¼ 0:001; ksproc9 ¼ 0:001;
kdproc9 ¼ 0:001; k0ac9 ¼ 0:001; k
00
aC9 ¼ 0:5Biophysical Journal 97(2) 415–434
p53 module (21 ODEs, 70 parameters, and wiring
diagram in Fig. 3)
d½DYRK2
dt
¼ kin  DNAdamage 
½DYRK2T½DYRK2 kout  ½DYRK2
d½p53helper
dt
¼ ksp53 

k
0
dp53 þ
½MDM2
1 þ 0:1  DNAdamage
	
 ½p53helper  kpp53  ½DYRK2  ½p53helper
Jpp53 þ ½p53helper
þ kdpp53  ½PP  ½p53killer
Jdpp53 þ ½p53killer
d½p53killer
dt
¼ kpp53  ½DYRK2  ½p53helper
Jpp53 þ ½p53helper 
kdpp53  ½PP  ½p53killer
Jdpp53 þ ½p53killer 

k
0
dp53 þ
½MDM2
1 þ 0:1  DNAdamage
	
 ½p53killer
d½ASPP
dt
¼ k0sASPP þ k
00
sASPP  ½E2F1  kdASPP  ½ASPP
d½MDM2
dt
¼ k0sMDM2 þ k
00
sMDM2  ½p53T

k
0
dMDM2 þ k
00
dMDM2  DNAdamage
  ½MDM2  kasAM  ½ARF
 ½MDM2 þ ðkdsAM þ kdARFÞ  ½ARF=MDM2
d½ARF
dt
¼ k0sARF þ k
00
sARF  ½E2F1  kdARF  ½ARF  kasAM  ½ARF  ½MDM2 þ kdsAM½ARF=MDM2
þ k0dMDM2 þ k00dMDM2  DNAdamage  ½ARF=MDM2
d½ARF=MDM2
dt
¼ kasAM  ½ARF  ½MDM2  kdsAM½ARF=MDM2 

k
0
dMDM2 þ k
00
dMDM2  DNAdamage

 ½ARF=MDM2  kdARF  ½ARF=MDM2
d½CycE
dt
¼ k0sE þ k
00
sE  ½E2F1  kdE  ½CycE  kasp21E  ½p21  ½CycE þ

kdsp21E þ kdp21
  ½p21=CycE
d½E2F1
dt
¼ kasRE  ½RB  ½E2F1 þ kdsRE  ½RB=E2F1
d½RBP
dt
¼ kpRB  ½CycE  ½RB
JpRB þ ½RB 
kdpRB  ½PP  ½RBP
JdpRB þ ½RBP
d½p21
dt
¼ k0sp21 þ k
00
sp21  ½p53helper þ k
000
sp21  ½p53killer  kdp21  ½p21  kasp21E  ½p21  ½CycE
þ kdsp21E þ kdE  ½p21=CycE
d½p21=CycE
dt
¼ kasp21E  ½p21  ½CycE  kdsp21E  ½p21=CycE  kdE  ½p21=CycE  kdp21  ½p21=CycE
ksC9 ¼ 0:001; kdC9 ¼ 0:002; kdaC9 ¼ 0:003;
k
0
aC3 ¼ 0:001; k
00
aC3 ¼ 0:02; k
000
aC3 ¼ 0:5; n ¼ 2
kdc3 ¼ 0:002; kas9x ¼ 0:1; kds9x ¼ 0:6; kd9x ¼ 0:2;
kas3x ¼ 0:2; kds3x ¼ 0:5; kd3x ¼ 0:1
kassx ¼ 2; kdssx ¼ 0:01; kdsx ¼ 0:007; ½XIAPT¼ 6
init ½ProC3 ¼ 1; ½ProC9 ¼ 1
Other variables start from initial values of 0:
To compute the bifurcation diagrams; set ½C9T ¼ 1
and ½C3T¼ 1;
and define ½ProC9 ¼ ½C9T½C9  ½aC9  ½XIAP=C9
and ½ProC3 ¼ ½C3T½C3  ½XIAP=C3
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d½BAX
dt
¼ ksBAX  kdBAX  ½BAX 

k f 1 þ k f 2  ½BH3AC
  ½BAX þ kb1  ½BAXm þ kb2  ½BAXm=BCL2
d½BAXm
dt
¼ k f 1 þ k f 2  ½BH3AC  ½BAX  kb1  ½BAXm  kdBAXm  ½BAXm  kasBAXmBCL  ½BAXm
 ½BCL2 þ kdsBAXmBCL  ½BAXm=BCL2
d½BCL2
dt
¼ ksBCL2  kdBCL2  ½BCL2  kasBAXmBCL  ½BAXm  ½BCL2 þ kdsBAXmBCL  ½BAXm=BCL2  kasBH3ACBCL
 ½BH3AC  ½BCL2 þ kdsBH3ACBCL ½BH3AC=BCL2kasBH3DRBCL½BH3DR½BCL2þ kdsBH3DRBCL
½BH3DR=BCL2þkb2½BAXm=BCL2
d½BH3AC
dt
¼ ksBH3AC  kdBH3AC  ½BH3AC  kasBH3ACBCL  ½BH3AC  ½BCL2 þ kdsBH3ACBCL  ½BH3AC=BCL2
d½BH3DR
dt
¼ ksBH3DR  kdBH3DR  ½BH3DR  kasBH3DRBCL  ½BH3R  ½BCL2 þ kdsBH3DRBCL  ½BH3DR=BCL2
d½BAXm=BCL2
dt
¼ kasBAXmBCL  ½BAXm  ½BCL2  kdsBAXmBCL  ½BAXm=BCL2  kb2  ½BAXm=BCL2  kdBAXmBCL
 ½BAXm=BCL2
d½BH3AC=BCL2
dt
¼ kasBH3ACBCL  ½BH3AC  ½BCL2  kdsBH3ACBCL  ½BH3AC=BCL2  kdBH3ACBCL  ½BH3AC=BCL2
d½BH3DR=BCL2
dt
¼ kasBH3DRBCL  ½BH3DR  ½BCL2  kdsBH3DRBCL  ½BH3DR=BCL2  kdBH3DRBCL  ½BH3DR=BCL2
d½p73
dt
¼ k0sp73 þ k00sp73  ½E2F1  kdp73  ½p73
½p53T¼ ½p53helper þ ½p53killer
½RB=E2F1 ¼ ½E2F1T½E2F1
½RB ¼ ½RBT½RBP  ½RB=E2F1
ksBH3AC ¼ k0sBH3AC þ k
00
sBH3AC  ð1 þ ½ASPPÞ  ½p53killer þ k
000
sBH3AC  ½p73 þ k
0000
sBH3AC  ð1 þ ½ASPPÞ  ½p53helper
ksBH3DR ¼ k0sBH3DR þ k
00
sBH3DR  ð1 þ ½ASPPÞ  ½p53killer þ k
000
sBH3DR  ½p73 þ k
0000
sBH3DR  ð1 þ ½ASPPÞ  ½p53helper
kin ¼ 0:00015; kout ¼ 0:0003; ½DYRK2T¼ 2; ksp53 ¼ 0:5; k
0
dp53 ¼ 0:1; kpp53 ¼ 1
Jpp53 ¼ 0:1; kdpp53 ¼ 0:5; Jdpp53 ¼ 0:1; ½PP ¼ 1; k0sASPP ¼ 0:01; k
00
sASPP ¼ 0:05; kdASPP ¼ 0:1
k
0
sMDM2 ¼ 0:02; k
00
sMDM2 ¼ 0:3; k
0
dMDM2 ¼ 0:1; k
00
dMDM2 ¼ 0:1; k
0
sARF ¼ 0:01; k
00
sARF ¼ 0:3; kdARF ¼ 0:1
kasAM ¼ 10; kdsAM ¼ 2; k0sE ¼ 0:01; k
00
sE ¼ 0:5; kdE ¼ 0:12; kasRE ¼ 5; kdsRE ¼ 1; kpRB ¼ 1
JpRB ¼ 0:1; kdpRB ¼ 0:5; JdpRB ¼ 0:1; ½RBT¼ 2; ½E2F1T¼ 1; k
0
sp21 ¼ 0:03; k
00
sp21 ¼ 0:3
k
000
sp21 ¼ 0:01; kdp21 ¼ 0:2; kasp21E ¼ 10; kdsp21E ¼ 1; ksBAX ¼ 0:97; kdBAX ¼ 0:01; kf1 ¼ 0:1
kf 2 ¼ 3:4; kb1 ¼ 4:2; kb2 ¼ 4:2; kdBAXm ¼ 0:01; kasBAXmBCL ¼ 87; kdsBAXmBCL ¼ 0:05
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432 Zhang et al.APPENDIX B: IT IS INVALID TO ASSUME BAXM IS
INACTIVATED ONLY FROM THE MONOMER FORM
If we assume that BAXm gets inactivated only from the monomer form, then
in resting cells (with [BH3] z 0), the concentration of BAXm will be
controlled by the rate equations
where [BAX] ¼ [BAX]T  [BAXm]F  [BAXm/BCL2] and [BCL2]F ¼
[BCL2]T  [BAXm/BCL2]. At steady state, the concentrations of BAXm
monomer and BAXm/BCL2 dimer are
½BAXmF¼
2Kd½BAXTﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
B2 þ 4AKd
p þ B; ½BAXm=BCL2
¼ ½BAXT

1 þ kb
k f 1
	
½BAXmF
where A ¼

1þ kb
kf 1

½BAXT; B ¼ ½BCL2T  ½BAXT þ Kd

1þ kb
kf 1

,
and Kd ¼ kdsBAXmBCL2
kasBAXmBCL2
. It is reasonable to assume that BCL2 binds tightly
to BAXm, i.e., Kd  [BAX]T, in which case,
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
B2 þ 4AKd
p
zjBj þ 2AKdjBj .
If [BAX]T < [BCL2]T, i.e., B > 0, then [BAXm]Fz 0 and [BAXm/BCL2]
z [BAX]T. In this case, in a resting cell, all BAX molecules pile up in the
mitochondrial membrane in combination with BCL2, in contradiction to the
fact that most BAX stays in the cytoplasm of resting cells (73,74).
To keep most BAX in the cytoplasm, we would have to assume that
[BAX]T > [BCL2]T, i.e., B < 0, in which case ½BAXmFy
½BAXT  ½BCL2T
1þ kb=kf 1 . To keep [BAXm]F low in a resting cell (to avoid acci-
dental apoptosis), kb must be much larger than kf1. In this case, it is very
difficult for BH3 proteins to activate BAX, because the rate of spontaneous
inactivation is very large. In our opinion, this is an unlikely scenario for
control of apoptosis.
Based on these considerations, we assume that BAXm can be inactivated
equally well as monomers and as dimers in combination with BCL2.
SUPPORTING MATERIAL
ode files are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(09)00970-9.
Tongli Zhang thanks John Albeck, John Burke, and Peter Sorger for sharing
their unpublished ideas and data, and Kathy Chen, Stefan Legewie, and
Zerrin Bagci for stimulating discussions.
This research was supported by grants from the United States National
Science Foundation to P.B. (DMS-0342283) and to K.I.T.P. (PHY05-
51164) and from Virginia Polytechnic Institute’s Institute for Critical Tech-
nologies and Applied Science to J.J.T.
REFERENCES
1. Johnstone, R. W., A. A. Ruefli, and S. W. Lowe. 2002. Apoptosis: a link
between cancer genetics and chemotherapy. Cell. 108:153–164.
2. Fulda, S., and K. M. Debatin. 2006. Extrinsic versus intrinsic apoptosis
pathways in anticancer chemotherapy. Oncogene. 25:4798–4811.
3. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell.
100:57–70.
4. Weinberg, R. A. 2007. The Biology of Cancer. Garland Science, New
York.
5. Green, D. R. 2000. Apoptotic pathways: paper wraps stone blunts scis-
sors. Cell. 102:1–4.
6. Meng, X. W., S. H. Lee, and S. H. Kaufmann. 2006. Apoptosis in the
treatment of cancer: a promise kept? Curr. Opin. Cell Biol. 18:668–676.
7. Albeck, J. G., J. M. Burke, B. B. Aldridge, M. Zhang, D. A. Lauffen-
burger, et al. 2008. Quantitative analysis of pathways controlling
extrinsic apoptosis in single cells. Mol. Cell. 30:11–25.
8. Rehm, M., H. Dussmann, R. U. Janicke, J. M. Tavare, D. Kogel, et al.
2002. Single-cell fluorescence resonance energy transfer analysis
ksBCL2 ¼ 0:57; kdBCL2 ¼ 0:01; kasBH3ACBCL ¼ 11:14; kdsBH3ACBCL ¼ 0:01; kasBH3DRBCL ¼ 11:14
kdsBH3DRBCL ¼ 0:01; kdBH3AC ¼ 0:01; kdBH3DR ¼ 0:01; kdBAXmBCL ¼ 0:01; kdBH3ACBCL ¼ 0:01
kdBH3DRBCL ¼ 0:01; k0sp73 ¼ 0:01; k
00
sp73 ¼ 0:01; kdp73 ¼ 0:5; k
0
sBH3AC ¼ 0:01; k
00
sBH3AC ¼ 0:05
k
000
sBH3AC ¼ 0:1; k
0000
sBH3AC ¼ 0:02; k
0
sBH3DR ¼ 0:01; k
00
sBH3DR ¼ 0:1; k
000
sBH3DR ¼ 0:1; k
0000
sBH3DR ¼ 0:02
init ½BAX ¼ 95; ½p53T¼ 0:78; ½ASPP ¼ 0:55; ½MDM2T¼ 2:53
init ½ARFT¼ 2:79; ½ARF=MDM2 ¼ 1:99; ½CycET¼ 3:83; ½E2F1 ¼ 0:9
init ½RBP ¼ 1:88; ½p21T¼ 1:32; ½p21=CycE ¼ 1:25; ½BCL2 ¼ 47:49
init ½BAXm=BCL2 ¼ 2:26; ½BH3AC=BCL2 ¼ 3:78; ½BH3DR=BCL2 ¼ 3:78; ½p73 ¼ 0:04
d½BAXmF
dt
¼ kf1  ½BAX  kb  ½BAXmFkasBAXmBCL2  ½BAXmF ½BCL2Fþ kdsBAXmBCL2  ½BAXm=BCL2
d½BAXm=BCL2
dt
¼ kasBAXmBCL2  ½BAXmF ½BCL2FkdsBAXmBCL2  ½BAXm=BCL2;Biophysical Journal 97(2) 415–434
Dynamics of Programmed Cell Death 433demonstrates that caspase activation during apoptosis is a rapid process.
Role of caspase-3. J. Biol. Chem. 277:24506–24514.
9. Aldridge, B. B., G. Haller, P. K. Sorger, and D. A. Lauffenburger. 2006.
Direct Lyapunov exponent analysis enables parametric study of tran-
sient signalling governing cell behaviour. IEE Syst. Biol. 153:425–432.
10. Bagci, E. Z., Y. Vodovotz, T. R. Billiar, G. B. Ermentrout, and I. Bahar.
2006. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial
permeability transition pores. Biophys. J. 90:1546–1559.
11. Bentele, M., I. Lavrik, M. Ulrich, S. Stosser, D. W. Heermann, et al.
2004. Mathematical modeling reveals threshold mechanism in CD95-
induced apoptosis. J. Cell Biol. 166:839–851.
12. Chen, C., J. Cui, H. Lu, R. Wang, S. Zhang, et al. 2007. Modeling of the
role of a Bax-activation switch in the mitochondrial apoptosis decision.
Biophys. J. 92:4304–4315.
13. Cui, J., C. Chen, H. Lu, T. Sun, and P. Shen. 2008. Two independent
positive feedbacks and bistability in the bcl-2 apoptotic switch. PLoS
ONE. 3:e1469.
14. Eissing, T., H. Conzelmann, E. D. Gilles, F. Allgower, E. Bullinger,
et al. 2004. Bistability analyses of a caspase activation model for
receptor-induced apoptosis. J. Biol. Chem. 279:36892–36897.
15. Fussenegger, M., J. E. Bailey, and J. Varner. 2000. A mathematical
model of caspase function in apoptosis. Nat. Biotechnol. 18:768–774.
16. Hua, F., M. G. Cornejo, M. H. Cardone, C. L. Stokes, and D. A. Lauf-
fenburger. 2005. Effects of Bcl-2 levels on Fas signaling-induced
caspase-3 activation: molecular genetic tests of computational model
predictions. J. Immunol. 175:985–995.
17. Legewie, S., N. Bluthgen, and H. Herzel. 2006. Mathematical modeling
identifies inhibitors of apoptosis as mediators of positive feedback and
bistability. PLoS Comput. Biol. 2:e120.
18. Rehm, M., H. J. Huber, H. Dussmann, and J. H. Prehn. 2006. Systems
analysis of effector caspase activation and its control by X-linked inhib-
itor of apoptosis protein. EMBO J. 25:4338–4349.
19. Albeck, J. G., J. M. Burke, S. L. Spencer, D. A. Lauffenburger, and
P. K. Sorger. 2008. Modeling a snap-action, variable-delay switch
controlling extrinsic cell death. PLoS Biol. 6:2831–2852.
20. Elledge, R. M., and W. H. Lee. 1995. Life and death by p53. Bioessays.
17:923–930.
21. Lu, X. 2005. p53: a heavily dictated dictator of life and death. Curr.
Opin. Genet. Dev. 15:27–33.
22. Michalak, E., A. Villunger, M. Erlacher, and A. Strasser. 2005. Death
squads enlisted by the tumour suppressor p53. Biochem. Biophys.
Res. Commun. 331:786–798.
23. Chipuk, J. E., and D. R. Green. 2006. Dissecting p53-dependent
apoptosis. Cell Death Differ. 13:994–1002.
24. Desagher, S., A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, et al.
1999. Bid-induced conformational change of Bax is responsible for
mitochondrial cytochrome c release during apoptosis. J. Cell Biol.
144:891–901.
25. Eskes, R., S. Desagher, B. Antonsson, and J. C. Martinou. 2000. Bid
induces the oligomerization and insertion of Bax into the outer mito-
chondrial membrane. Mol. Cell. Biol. 20:929–935.
26. Marani, M., T. Tenev, D. Hancock, J. Downward, and N. R. Lemoine.
2002. Identification of novel isoforms of the BH3 domain protein Bim
which directly activate Bax to trigger apoptosis. Mol. Cell. Biol.
22:3577–3589.
27. Chipuk, J. E., L. Bouchier-Hayes, and D. R. Green. 2006. Mitochon-
drial outer membrane permeabilization during apoptosis: the innocent
bystander scenario. Cell Death Differ. 13:1396–1402.
28. Green, D. R. 2005. Apoptotic pathways: ten minutes to dead. Cell.
121:671–674.
29. Riedl, S. J., and Y. Shi. 2004. Molecular mechanisms of caspase regu-
lation during apoptosis. Nat. Rev. Mol. Cell Biol. 5:897–907.
30. Holcik, M., and R. G. Korneluk. 2001. XIAP, the guardian angel. Nat.
Rev. Mol. Cell Biol. 2:550–556.31. Cummins, J. M., M. Kohli, C. Rago, K. W. Kinzler, B. Vogelstein, et al.
2004. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant
modulator of tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-mediated apoptosis in human cancer cells. Cancer Res.
64:3006–3008.
32. Lakhani, S. A., A. Masud, K. Kuida, G. A. Porter, Jr., C. J. Booth, et al.
2006. Caspases 3 and 7: key mediators of mitochondrial events of
apoptosis. Science. 311:847–851.
33. Finucane, D. M., E. Bossy-Wetzel, N. J. Waterhouse, T. G. Cotter, and
D. R. Green. 1999. Bax-induced caspase activation and apoptosis via
cytochrome c release from mitochondria is inhibitable by Bcl-xL. J.
Biol. Chem. 274:2225–2233.
34. Murphy, K. M., V. Ranganathan, M. L. Farnsworth, M. Kavallaris, and
R. B. Lock. 2000. Bcl-2 inhibits Bax translocation from cytosol to mito-
chondria during drug-induced apoptosis of human tumor cells. Cell
Death Differ. 7:102–111.
35. Shiozaki, E. N., J. Chai, and Y. Shi. 2002. Oligomerization and activa-
tion of caspase-9, induced by Apaf-1 CARD. Proc. Natl. Acad. Sci.
USA. 99:4197–4202.
36. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, and E. S. Al-
nemri. 1998. Autoactivation of procaspase-9 by Apaf-1-mediated olig-
omerization. Mol. Cell. 1:949–957.
37. Zou, H., R. Yang, J. Hao, J. Wang, C. Sun, et al. 2003. Regulation of the
Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem.
278:8091–8098.
38. Suzuki, Y., Y. Nakabayashi, and R. Takahashi. 2001. Ubiquitin-protein
ligase activity of X-linked inhibitor of apoptosis protein promotes pro-
teasomal degradation of caspase-3 and enhances its anti-apoptotic effect
in Fas-induced cell death. Proc. Natl. Acad. Sci. USA. 98:8662–8667.
39. MacFarlane, M., W. Merrison, S. B. Bratton, and G. M. Cohen. 2002.
Proteasome-mediated degradation of Smac during apoptosis: XIAP
promotes Smac ubiquitination in vitro. J. Biol. Chem. 277:36611–36616.
40. Shiozaki, E. N., J. Chai, D. J. Rigotti, S. J. Riedl, P. Li, et al. 2003.
Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell.
11:519–527.
41. Sharpless, N. E., and R. A. DePinho. 2007. Cancer biology: gone but
not forgotten. Nature. 445:606–607.
42. Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and
negative feedback loops. Oncogene. 24:2899–2908.
43. Mowat, M. R. 1998. p53 in tumor progression: life, death, and every-
thing. Adv. Cancer Res. 74:25–48.
44. Oren, M. 2003. Decision making by p53: life, death and cancer. Cell
Death Differ. 10:431–442.
45. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes
Dev. 12:2984–2991.
46. Olsson, A., C. Manzl, A. Strasser, and A. Villunger. 2007. How im-
portant are post-translational modifications in p53 for selectivity in
target-gene transcription and tumour suppression? Cell Death Differ.
14:1561–1575.
47. Csikasz-Nagy, A., D. Battogtokh, K. C. Chen, B. Novak, and J. J. Tyson.
2006. Analysis of a generic model of eukaryotic cell-cycle regulation.
Biophys. J. 90:4361–4379.
48. Zhang, T., P. Brazhnik, and J. J. Tyson. 2007. Exploring mechanisms of
the DNA-damage response: p53 pulses and their possible relevance to
apoptosis. Cell Cycle. 6:85–94.
49. Yu, J., and L. Zhang. 2003. No PUMA, no death: implications for p53-
dependent apoptosis. Cancer Cell. 4:248–249.
50. Dynlacht, B. D. 2005. E2F and p53 make a nice couple: converging
pathways in apoptosis. Cell Death Differ. 12:313–314.
51. Ginsberg, D. 2007. EGFR signaling inhibits E2F1-induced apoptosis
in vivo: implications for cancer therapy. Sci. STKE. 2007:pe4.
52. Irwin, M., M. C. Marin, A. C. Phillips, R. S. Seelan, D. I. Smith, et al.
2000. Role for the p53 homologue p73 in E2F–1-induced apoptosis.
Nature. 407:645–648.Biophysical Journal 97(2) 415–434
434 Zhang et al.53. Braithwaite, A. W., G. Del Sal, and X. Lu. 2006. Some p53-binding
proteins that can function as arbiters of life and death. Cell Death Differ.
13:984–993.
54. Furukawa, Y., N. Nishimura, Y. Furukawa, M. Satoh, H. Endo, et al.
2002. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem.
277:39760–39768.
55. Nahle, Z., J. Polakoff, R. V. Davuluri, M. E. McCurrach, M. D. Jacob-
son, et al. 2002. Direct coupling of the cell cycle and cell death
machinery by E2F. Nat. Cell Biol. 4:859–864.
56. Bode, A. M., and Z. Dong. 2004. Post-translational modification of p53
in tumorigenesis. Nat. Rev. Cancer. 4:793–805.
57. Toledo, F., and G. M. Wahl. 2006. Regulating the p53 pathway: in vitro
hypotheses, in vivo veritas. Nat. Rev. Cancer. 6:909–923.
58. Aylon, Y., and M. Oren. 2007. Living with p53, dying of p53. Cell.
130:597–600.
59. Taira, N., K. Nihira, T. Yamaguchi, Y. Miki, and K. Yoshida. 2007.
DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphor-
ylation in the apoptotic response to DNA damage. Mol. Cell. 25:725–
738.
60. Brazhnik, P., and J. J. Tyson. 2006. Cell cycle control in bacteria and
yeast: a case of convergent evolution? Cell Cycle. 5:522–529.
61. Chen, K. C., L. Calzone, A. Csikasz-Nagy, F. R. Cross, B. Novak, et al.
2004. Integrative analysis of cell cycle control in budding yeast. Mol.
Biol. Cell. 15:3841–3862.
62. Eissing, T., F. Allgower, and E. Bullinger. 2005. Robustness properties
of apoptosis models with respect to parameter variations and intrinsic
noise. Syst. Biol. (Stevenage). 152:221–228.
63. Goldstein, J. C., N. J. Waterhouse, P. Juin, G. I. Evan, and D. R. Green.
2000. The coordinate release of cytochrome c during apoptosis is rapid,
complete and kinetically invariant. Nat. Cell Biol. 2:156–162.
64. Chandra, D., J. W. Liu, and D. G. Tang. 2002. Early mitochondrial acti-
vation and cytochrome c up-regulation during apoptosis. J. Biol. Chem.
277:50842–50854.Biophysical Journal 97(2) 415–43465. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis.
Science. 281:1309–1312.
66. Martin, A. G., and H. O. Fearnhead. 2002. Apocytochrome c blocks cas-
pase-9 activation andBax-induced apoptosis. J. Biol. Chem. 277:50834–
50841.
67. Willis, S. N., J. I. Fletcher, T. Kaufmann, M. F. van Delft, L. Chen, et al.
2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2
homologs, not Bax or Bak. Science. 315:856–859.
68. Harlin, H., S. B. Reffey, C. S. Duckett, T. Lindsten, and C. B. Thomp-
son. 2001. Characterization of XIAP-deficient mice. Mol. Cell. Biol.
21:3604–3608.
69. Seoane, J., H. V. Le, and J. Massague. 2002. Myc suppression of the
p21(Cip1) Cdk inhibitor influences the outcome of the p53 response
to DNA damage. Nature. 419:729–734.
70. Geva-Zatorsky, N., N. Rosenfeld, S. Itzkovitz, R. Milo, A. Sigal, E. De-
kel, T.Yarnitzky,Y. Liron, P. Polak,G. Lahav, andU.Alon. 2006.Oscil-
lations and variability in the p53 system.Mol. Syst. Biol. 2:2006.0033.
71. Hamstra, D. A., M. S. Bhojani, L. B. Griffin, B. Laxman, B. D. Ross,
et al. 2006. Real-time evaluation of p53 oscillatory behavior in vivo
using bioluminescent imaging. Cancer Res. 66:7482–7489.
72. Ley, R., K. Balmanno, K. Hadfield, C. Weston, and S. J. Cook. 2003.
Activation of the ERK1/2 signaling pathway promotes phosphorylation
and proteasome-dependent degradation of the BH3-only protein, Bim.
J. Biol. Chem. 278:18811–18816.
73. Schuler, M., U. Maurer, J. C. Goldstein, F. Breitenbucher, S. Hoffarth,
et al. 2003. p53 triggers apoptosis in oncogene-expressing fibroblasts by
the induction of Noxa and mitochondrial Bax translocation. Cell Death
Differ. 10:451–460.
74. Smaili, S. S., Y. T. Hsu, K. M. Sanders, J. T. Russell, and R. J. Youle.
2001. Bax translocation to mitochondria subsequent to a rapid loss of
mitochondrial membrane potential. Cell Death Differ. 8:909–920.
